Risk of Hemolytic Anemia in IBD Patients with Glucose-6-Phosphate Dehydrogenase Deficiency Treated with Mesalamine: Results of a Retrospective-Prospective and Ex Vivo Study.
J Clin Med
; 12(14)2023 Jul 20.
Article
in En
| MEDLINE
| ID: mdl-37510911
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Clinical_trials
/
Etiology_studies
/
Risk_factors_studies
Language:
En
Journal:
J Clin Med
Year:
2023
Document type:
Article
Affiliation country:
Italia